ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 29, Issue 4, Pages 508-517
Publisher
Wiley
Online
2014-02-12
DOI
10.1002/mds.25817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
- (2013) Maryka Quik et al. BIOCHEMICAL PHARMACOLOGY
- Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease
- (2013) Maryka Quik et al. MOVEMENT DISORDERS
- TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque
- (2013) Tom H. Johnston et al. NEUROPHARMACOLOGY
- α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
- (2013) Maryka Quik et al. NEUROPHARMACOLOGY
- Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease
- (2012) Susan Duty CNS DRUGS
- Emerging therapies for Parkinsonʼs disease
- (2012) Werner Poewe et al. CURRENT OPINION IN NEUROLOGY
- Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: Correlation with desensitization of α4β2* receptors
- (2012) Jiahui Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- (2012) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder
- (2012) Earle E. Bain et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nicotine as a potential neuroprotective agent for Parkinson's disease
- (2012) Maryka Quik et al. MOVEMENT DISORDERS
- Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
- (2012) Maryka Quik et al. NEUROBIOLOGY OF DISEASE
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
- (2012) Earle E Bain et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain
- (2012) Michael C. Rowbotham et al. PAIN
- Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
- (2011) Damien Toulorge et al. FASEB JOURNAL
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
- (2011) Mahmoud M. Iravani et al. JOURNAL OF NEURAL TRANSMISSION
- Nicotine Reduces L-DOPA-Induced Dyskinesias by Acting at 2* Nicotinic Receptors
- (2011) L. Z. Huang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
- (2011) Luping Z. Huang et al. NEUROPHARMACOLOGY
- Nicotine Alters Limbic Function in Adolescent Rat by a 5-HT1A Receptor Mechanism
- (2011) Jasmin M Dao et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia
- (2011) O.A. Timofeeva et al. NEUROSCIENCE
- Striatal plasticity in Parkinson's disease and L-DOPA induced dyskinesia
- (2011) M.M. Iravani et al. PARKINSONISM & RELATED DISORDERS
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
- (2011) Véronique Sgambato-Faure et al. PROGRESS IN NEUROBIOLOGY
- Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
- (2011) George Apostol et al. PSYCHOPHARMACOLOGY
- Nicotinic Receptor-Mediated Reduction in L-DOPA-Induced Dyskinesias May Occur via Desensitization
- (2010) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
- (2010) Alexxai V. Kravitz et al. NATURE
- Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system
- (2010) Fernando Berrendero et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Differential effects of serotonin (5-HT)2receptor-targeting ligands on locomotor responses to nicotine-repeated treatment
- (2010) Magdalena Zaniewska et al. SYNAPSE
- Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination
- (2009) David J. Anderson et al. BIOCHEMICAL PHARMACOLOGY
- Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain
- (2009) Michael J. Marks et al. BIOCHEMICAL PHARMACOLOGY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
- Interactions of serotonin (5-HT)2receptor-targeting ligands and nicotine: Locomotor activity studies in rats
- (2009) Magdalena Zaniewska et al. SYNAPSE
- Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
- (2008) Edward D. Levin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Parkinson's disease: Levodopa-induced dyskinesia and signal transduction
- (2008) Emanuela Santini et al. FEBS Journal
- Diversity of vertebrate nicotinic acetylcholine receptors
- (2008) Neil S. Millar et al. NEUROPHARMACOLOGY
- Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
- (2008) Roberta J. Ward et al. PROGRESS IN NEUROBIOLOGY
- Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- (2007) Marina et al. Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started